OBIO Competitors & Alternatives
Compare Orchestra BioMed Holdings Inc. with similar stocks in the same industry
Biotechnology
OBIO
Main Stock$5.58
Tradestie Score
60
Market Cap
$137.59M
Revenue Growth
-0.9%
Analyst Upside
+122.7%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$10.24
|
$386.68M | - | 61 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$6.23
|
$382.04M | - | 59 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$13.06
|
$371.64M | - | 61 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$14.06
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$38.78
|
$353.70M | 392.3 | 46 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.39
|
$350.98M | - | 62 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.70
|
$332.96M | - | 52 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.63
|
$328.62M | - | 51 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.12
|
$307.12M | - | 63 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$8.05
|
$304.12M | - | 59 | Compare |
More OBIO Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 3841)
223 stocks in this industry